Oxygen
Myeloma
University of RochesterSmall moleculeEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
16 Active assets in the Myeloma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
SULFAMETHOXAZOLE Monash University | Phase 3 | BB |
Trimethoprim Monash University | Phase 3 | BB |
HUMAN IMMUNOGLOBULINS Monash University | Phase 2/3 | BB |
Lipitor Fred Hutchinson Cancer Center | Phase 2 | BB |
Campath Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 | B |
View all 43 →
Same molecule, other indications
Oxygen is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →